Ayurvedic treatment of Immature Cataract

A clinical consensus study for the development of Standard Operating Procedure and practice guidelines for Anjana Karma with a Feasibility study in immature cataract - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106754

Enrollment

Registered

2026-03-23

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H25- Age-related cataract

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects of age 40-70 years 2.Subjects who agree to participate in the study and submit a written informed consent form 3. Willing and able to participate for 1 week 4. Diagnosed cases of immature cataract who are not receiving any specific treatment.

Exclusion criteria

Exclusion criteria: 1.Subjects who have active corneal ulceration, corneal opacity, keratitis,trauma etc 2.Uncontrolled diabetes mellitus (DM) (HbA1c MORE THAN 8) and Uncontrolled hypertension (Systolic BP higher than 160mmHg and/or Diastolic BP higher than 100mmHg) 3.Subjects suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Psycho-Neuro-endocrinal disorders, etc.) 4. Subjects with concurrent Hepatic Dysfunction (defined as AST and or ALT more than 2 times of the upper normal limit) or Renal Dysfunction ((defined as S. Creatinine above 1.2mg/dL or an eGFR below 60 mL/min/1.73 m2 ), uncontrolled Pulmonary Dysfunction (asthmatic and COPD subjects). 5. Alcoholics and/or drug abusers 6. Patients with evidence of malignancy 7.H/O Hypersensitivity to the trial drug or any of its ingredients 8. Subjects who have completed participation in any other clinical trial during the past six months. 9. Any other condition which the Investigator thinks may jeopardize the study.

Design outcomes

Primary

Measure	Time frame
1. Changes in visual acuity by Snellen s Chart [Change in at least 1 line] Timepoint: baseline and after 7 days	—

Secondary

Measure	Time frame
Any SAE /ADRTimepoint: baseline and after 7 days	—

Countries

India

Contacts

Public ContactDR Praveen Balakrishnan

Central Ayurveda Research Institute New Delhi

drshwetamataccras@gmail.com8866014946

Outcome results